Following previous GBD studies, mortality and population are estimated for 23 age groups: early neonatal (0–6 days), late neonatal (7–27 days), post-neonatal (28–365 days), 1–4 years, 5–9 years, every 5-year age group up to 95 years, and 95 years and older. Age-specific fertility is estimated for 5-year age groups between ages 10 years and 54 years.
Fertility
It involves the biological processes that allow for successful reproduction, including the production of healthy gametes, fertilization, and embryo development.
Factors that influence fertility include age, hormonal balance, reproductive organ function, and overall health status.
Infertility, or the inability to conceive after a year of unprotected intercourse, can have various underlying causes that may be treatable through medical interventions.
Reseach into fertility treatments and optimization of reproductive protocols is an important area of study to help individuals and couples achieve their family-building goals.
Most cited protocols related to «Fertility»
Following previous GBD studies, mortality and population are estimated for 23 age groups: early neonatal (0–6 days), late neonatal (7–27 days), post-neonatal (28–365 days), 1–4 years, 5–9 years, every 5-year age group up to 95 years, and 95 years and older. Age-specific fertility is estimated for 5-year age groups between ages 10 years and 54 years.
For GBD 2019, we instituted the GBD standard location list, which consists of all national-level locations as well as subnational locations in the UK, India, China, and the USA. In each modelling step, effects of the covariates were derived from empirical data observed from standard locations. This ensured that our estimates were derived from robust relationships extrapolated from locations with more robust empirical data, thus ensuring long-term stability in our estimates.
Below, we provide a high-level description of each analytical component, with an emphasis on new steps and other updates for GBD 2019. Methods used in the GBD demographic estimation process have been described extensively in previous publications,14 (link), 15 (link), 16 , 17 (link), 18 (link) and additional detail on estimation for the 2019 cycle is available in
This study complies with GATHER;19 (link) a completed GATHER checklist is available in
Most recents protocols related to «Fertility»
Example 21
There is growing evidence that bisphenol A (BPA) may adversely affect humans. BPA is an endocrine disruptor that has been shown to be harmful in laboratory animal studies. As reported by Rochester J (Reproductive Toxicology, 2013) BPA has been shown to affect many endpoints of fertility, including poor ovarian response, viability of oocytes, and reduced yield of viable oocytes. BPA has also been correlated with PCOS, endometrial disorders, an increased rate of miscarriages, premature delivery, and lower birth weights.
Current methods of detecting BPA in blood are done through mass spectrometry. Monitoring of BPA levels in blood may help reduce or eliminate certain sources of BPA in a women's environment, aiding in overall health.
In some embodiments the disclosed device focuses on detecting levels of BPA toxin from menstrual blood or cervicovaginal fluid.
Example 1
Variety 18GG0453L has shown uniformity and stability for all traits, as described in the following variety description information. The variety has been increased with continued observation for uniformity.
Table 1 provides data on morphological, agronomic, and quality traits for 18GG0453L. When preparing the detailed phenotypic information, plants of the new 18GG0453L variety were observed while being grown using conventional agronomic practices.
Example 20
Fertility—Progesterone is one of the most important hormones for pregnancy with myriad functions from ensuring implantation of the egg into a healthy uterine wall, to ensuring embryo survival and prevention of immune rejection of the developing baby. Many other hormones act in concert with progesterone, like Follicular Stimulating Hormone (FSH) and Luteinizing Hormone (LH) and can be used to assess optimal fertility windows on a monthly basis. And in fact an over dominant production of estrogen can lead to progesterone deficiency and thus difficulty getting or staying pregnant. It is important that women not only monitor FSH and LH to determine optimal fertility for getting pregnant, but ensure that sufficient levels or progesterone are being produced to ensure pregnancy and viability of the fetus. A study from the British Medical Journal, 2012, demonstrated that a single progesterone level test can help discriminate between viable and nonviable pregnancies. Among women who had an ultrasound, 73 percent had nonviable pregnancies. But among women with progesterone levels below 3 to 6 nanograms per milliliter, the probability of a nonviable pregnancy rose to more than 99 percent (Gallos L et al. British Medical J, 2012).
Perimenopause—Monitoring hormone levels during the menopausal transition may help women better understand important changes in their body and allow them to make more informed decisions about health, diet, and lifestyle. According to Hale G E (Best Pract Res Clin Obstet Gynaecol, 2009), data from endocrine studies on women throughout the menopausal transition show changes in levels of steroid hormones and gonadotropins (Progesterone, Estrodiol, LH, FSH and AMH) and follicle-stimulating hormone undergoes the first detectable change while menstrual cycles remain regular. Erratic and less predictable changes in steroid hormones follow, especially with the onset of irregular cycles. Later serum hormone studies on the inhibins and anti-Mullerian hormone established that diminishing ovarian follicle number contributes to the endocrine changes with advancing reproductive age.
Many fertility issues revolve around genetic, anatomical or other disorders that may either prevent a woman from becoming pregnant and/or staying pregnant. Some of these disorders include hormonal imbalances, diabetes, a short or insufficient cervix, and acute or chronic infections. A cascade of genes has been implicated in the occurrence of getting and staying pregnant. These genes have been studied using genotyping, gene expression, and proteomic analysis to assess a woman's ability to stay pregnant.
In some embodiments the disclosed device focuses on detecting levels of Progesterone, LH, FSH, Estrodiol, AMH, genotyping, gene expression through RNA and methylome sequencing, qPCR and proteomic analysis for fertility and menopause management from menstrual blood or cervicovaginal fluid.
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Top products related to «Fertility»
More about "Fertility"
This includes the production of healthy gametes, fertilization, and embryo development.
Factors like age, hormonal balance, reproductive organ function, and overall health status can influence fertility.
Infertility, the inability to conceive after a year of unprotected intercourse, can have various underlying causes that may be treatable through medical interventions.
Researching fertility treatments and optimizing reproductive protocols is crucial to help individuals and couples achieve their family-building goals.
Synonyms and related terms for fertility include fecundity, reproductive capacity, and procreative potential.
Abbreviations like IVF (in vitro fertilization) and ART (assisted reproductive technology) are commonly used in the field.
Key subtopics include gamete production, hormonal regulation, fertilization, embryo development, and infertility causes and treatments.
Tools like SAS 9.4, GraphPad Prism 5, Prism 6, Prism 7, and Prism 8 can be used for statistical analysis and data visualization in fertility research.
HCG (human chorionic gonadotropin) is a hormone important in fertility and pregnancy.
C57BL/6 and C57BL/6J mice are commonly used animal models in fertility studies.
TRIzol reagent is a popular method for RNA extraction in reproductive biology research.
PubCompare.ai revolutionizes fertility research by using AI-driven protocol optimization.
It helps researchers locate the best protocols from literature, pre-prints, and patents, and leverages AI-powered comparisons to identify the most effective treatments and products.
This cutting-edge technology streamlines fertility research, empowering scientists to make informed decisions and advance the field.